Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling

Published:2018-05-15 Issue:5 Volume:13 Page:e0197422
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Beckwitt Colin H.,Shiraha Keisuke,Wells Alan^ORCID

Funder

U.S. Department of Veterans Affairs

National Center for Advancing Translational Sciences

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Cancer statistics;RL Siegel;CA Cancer J Clin,2016

2. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition;YL Chao;Mol Cancer,2010

3. Models, mechanisms and clinical evidence for cancer dormancy;JA Aguirre-Ghiso;Nat Rev Cancer,2007

4. Dissemination and growth of cancer cells in metastatic sites;AF Chambers;Nat Rev Cancer,2002

5. The Dormancy Dilemma: Quiescence versus Balanced Proliferation;A Wells;Cancer Res,2013

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer;International Journal of Molecular Sciences;2024-09-04

2. Regulatory effects of statins on Akt signaling for prevention of cancers;Cellular Signalling;2024-08

3. Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells;Biology;2024-06-19

4. Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis;Clinical and Experimental Medicine;2024-06-12

5. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer;International Journal of Surgery;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3